Introduction Patients with chronic thromboembolic pulmonary hypertension (CTEPH) and
decompensated right heart failure (DRHF) have worse outcomes after pulmonary …

Purpose To perform a systematic review and meta-analysis assessing the safety and
efficacy of balloon pulmonary angioplasty (BPA) in the treatment of chronic thromboembolic …

Background The outcome of patients with chronic thromboembolic pulmonary hypertension
(CTEPH) undergoing pulmonary endarterectomy (PEA) after urgent hospitalization for …

Background The impact of male sex as a determinant of health outcomes in systemic
sclerosis-associated pulmonary arterial hypertension (SSc-PAH) is controversial. The …

Background Despite a major reduction in pulmonary vascular resistance (PVR), patients
with chronic thromboembolic pulmonary hypertension (CTEPH) do not always return to …

Background Chronic thromboembolic pulmonary hypertension (CTEPH) is still largely
underdiagnosed in the general population. Although transthoracic echocardiogram (TTE) is …

Rosai Dorfman disease, also known as sinus histiocytosis with massive lymphadenopathy,
is a rare histiocytic disorder that typically presents as painless cervical adenopathy …

Objective.—To determine if there is an association between migraines and intrapulmonary
right‐to‐left shunt. Background.—Several studies have described an association between …

Background Pulmonary endarterectomy (PEA) in severe chronic thromboembolic pulmonary
hypertension (CTEPH) is associated with higher risks. However, recent evidence suggests …

Background Pulmonary endarterectomy (PEA) is the treatment of choice for patients with
chronic thromboembolic pulmonary hypertension (PH). However, this surgery remains …